Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript
…
0,635€
1,63%
Echtzeit-Aktienkurs Seres Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Seres Therapeutics Inc. Aktie
Seres Therapeutics chief legal officer sells $2,939 in stock By Investing.com
Seres Therapeutics chief legal officer sells $2,939 in stock…
Seres Therapeutics executive sells shares worth $2,058 By Investing.com
Seres Therapeutics executive sells shares worth $2,058…
Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript
…
Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today…
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass, June 07, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a…
Seres Therapeutics executive sells shares worth $882 By Investing.com
Seres Therapeutics executive sells shares worth $882…
Seres Therapeutics executive sells shares worth $660 By Investing.com
Seres Therapeutics executive sells shares worth $660…
Seres Therapeutics CEO sells $2,288 in stock By Investing.com
Seres Therapeutics CEO sells $2,288 in stock…
Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript
…
Seres Therapeutics stock target cut to $5, maintains Outperform rating By Investing.com
Seres Therapeutics stock target cut to $5, maintains Outperform rating…
Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript
…
Seres Therapeutics Q4 2023 Earnings Preview
…
Seres Therapeutics appoints new CFO as Arkowitz retires By Investing.com
Seres Therapeutics appoints new CFO as Arkowitz retires…